Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the brain. Although measurements of GABA levels in vivo in the human brain using edited proton magnetic resonance spectroscopy ( 1 H-MRS) have been established for some time, it is has not been established how regional GABA levels vary with age in the normal human brain. In this study, 49 healthy men and 51 healthy women aged between 20 and 76 years were recruited and J-difference edited spectra were recorded at 3 T to determine the effect of age on GABA levels, and to investigate whether there are regional and gender differences in GABA in mesial frontal and parietal regions. Because the signal detected at 3.02 ppm using these experimental parameters is also expected to contain contributions from both macromolecules (MM) and homocarnosine, in this study the signal is labeled GABA+ rather than GABA. Significant negative correlations were observed between age and GABA+ in both regions studied (GABA +/Cr: frontal region, r = − 0.68, p b 0.001, parietal region, r = − 0.54, p b 0.001; GABA +/NAA: frontal region, r = − 0.58, p b 0.001, parietal region, r = − 0.49, p b 0.001). The decrease in GABA + with age in the frontal region was more rapid in women than men. Evidence of a measureable decline in GABA is important in considering the neurochemical basis of the cognitive decline that is associated with normal aging.
Introduction
The adult brain changes throughout adult life, with frontal development extending well beyond childhood (Giedd et al., 2010; Jernigan et al., 1991; Lovden et al., 2010) , and growing evidence of a gradual decline in some aspects of function with age (Betts et al., 2007; Wilson et al., 2011; Zhang et al., 2011) .
Gamma-aminobutyric acid (GABA) is the main inhibitory neurotransmitter in the human brain (McCormick, 1989) , and GABAergic inhibition plays a key role in shaping and controlling cortical glutamatergic excitation (Brunel and Wang, 2003; Buzsaki et al., 2007; Kohn and Whitsel, 2002) . Several recent studies (Hua et al., 2008; Leventhal et al., 2003; Stanley et al., 2012) have suggested a decline in GABAergic function with age and that is associated with a loss of function (Betts et al., 2007; Lenz et al., 2012; Leventhal et al., 2003; Wilson et al., 2011; Zhang et al., 2011) . While GABA levels can be measured non-invasively in the human brain using magnetic resonance spectroscopy (MRS) (Puts and Edden, 2012) , to date there has been a paucity of studies exploring the normal age-related variations in regional GABA levels.
The purpose of this study, therefore, was to characterize the age-dependence of MRS measures of GABA, a metric that has recently been closely associated with cognitive function (Northoff et al., 2007; Boy et al., 2011a,b; Edden et al., 2009; Muthukumaraswamy et al., 2009 Muthukumaraswamy et al., , 2012 Puts et al., 2011; Sumner et al., 2010) . Measurement of intra-cerebral GABA using MRS is hindered because resonances of GABA overlap with other metabolites such as glutamate (Glu), N-acetylaspartate (NAA), total creatine (Cr) and macromolecules (MM), and the concentration of GABA is relatively low (0.5-1.9 mmol/dm 3 ) (Govindaraju et al., 2000) . Measurements of GABA largely free from overlap with more abundant molecules have been established using spectral-editing techniques (Mescher et al., 1998; Rothman et al., 1993) , and this has been applied successfully to measure GABA in a number of neurologic, psychiatric and developmental disorders Goddard et al., 2004; Kaufman et al., 2009; Petroff et al., 2001; Pollack et al., 2008; Sanacora et al., 1999; Tayoshi et al., 2010) and in healthy control subjects (Boy et al., 2011a; NeuroImage 78 (2013) Edden et al., 2009; Evans et al., 2010; Puts and Edden, 2012; Puts et al., 2011; Stagg et al., 2009; Sumner et al., 2010) .
In this study, J-difference edited MRS was used to investigate effects of age on GABA levels in frontal and parietal regions, and to investigate whether these effects are gender-specific.
Material and methods

Subjects
One hundred healthy volunteers (49 men and 51 women) were recruited from the local community. The study was approved by the local institutional review board and each participant provided informed consent. The study participants were between 20 and 76 years old (men: range 24-76, mean = 46.1 ± 14.5 years; women: range 20-70, mean = 45.0 ± 14.7 years) and were recruited to represent an even distribution of ages: 20 participants (9 male, 11 female) aged 20-30 years; 20 participants (10 male, 10 female) aged 31-40 years; 20 participants (10 male, 10 female) aged 41-50 years; 20 participants (11 male, 9 female) aged 51-60 years; and 20 participants (9 male, 11 female) aged 61-76 years. All subjects were in good health, and had no history of neurological or psychiatric disease, or use of psychotropic medication. Smoking, drinking alcohol and taking caffeine were prohibited for 12 h prior to MR measurement.
MRI and voxel localization
All subjects were scanned on a 3 T scanner (Philips 'Achieva' TX, Best, The Netherlands) using an eight-channel phased-array head coil receiver. T1-weighted three-dimensional TFE images were used as a localizer, acquired with the following parameters: TR = 8.2 ms; TE = 3.7 ms; slice thickness = 1 mm; matrix 256 × 256; field of view = 24 × 24 cm 2 ; and flip angle = 8°. Images were reconstructed with 1 × 1 × 1 mm 3 isotropic voxels. The volume of interest (VOI) with a size of 3 × 3 × 3 cm 3 was chosen in the two areas: (a) frontal and (b) parietal regions (see Figs. 1a and b) . The median sagittal plane was chosen as a reference slice for voxel localization: the voxel in the frontal region was prescribed superior to the genu of the corpus callosum, aligned with the shape of the corpus callosum, and positioned on the medial aspect of the axial plane; the voxel in the parietal region was prescribed posterior and superior to the splenium of the corpus callosum, aligned with the shape of the corpus callosum, and positioned again on the medial aspect of the axial plane. All of the VOIs were placed in a manner that enabled avoidance of the lateral ventricle and skull.
H-MRS spectroscopy, editing, and VOI segmentation
The 3 ppm resonance of GABA was measured using a MEGA-PRESS sequence (Mescher et al., 1998) , using the following parameters: TR 2000 ms; TE 68 ms; 320 averages; acquisition bandwidth 1000 Hz; and total acquisition time 11 min. During odd-numbered acquisitions, a frequency-selective, Gaussian inversion pulse was applied to the 3 CH 2 resonance of GABA at 1.9 ppm, affecting the weakly J-coupled triplet peak at 3.02 ppm (EDIT-ON). During even-numbered acquisitions, the same pulse was applied symmetrically to the other side of the water peak, at 7.5 ppm (EDIT-OFF), in order to minimize the residual water signal upon subtraction. The resulting edited spectrum is derived from the difference between the ON and OFF spectra. Chemical Shift Selective Suppression (CHESS) was used for water suppression. FASTMAP shimming of the VOI was performed automatically prior to each acquisition.
Because the signal detected at 3.02 ppm using these experimental parameters is also expected to contain contributions from both macromolecules (MM) and homocarnosine (Rothman et al., 1997) , in the rest of this manuscript this signal is labeled GABA+ rather than GABA, to indicate the potential presence of these other compounds. All the metabolite quantitation was performed with time-domain fitting algorithm AMARES, within jMRUI v.4.0 software (Stefan et al., 2009) . A 3 Hz exponential line broadening was applied. GABA+ levels were evaluated as both GABA+/Cr and GABA+/NAA in order to demonstrate that observed effects are driven by GABA+. The internal reference of Cr and NAA methyl singlet signals was obtained from the 'OFF' MEGA-PRESS spectra. Additionally, the co-edited Glx (glutamate + glutamine) signal at 3.7 ppm was evaluated in the difference spectra. The AMARES fitting algorithm within jMRUI provides the standard deviation of the amplitude (the Cramer-Rao standard deviation [CRSD]), which can be used as a measure of the accuracy of the calculation of the amplitude of a certain component, reflecting the signal-to-noise ratio (Lamb et al., 1996) . The CRSD of the GABA+ signal was divided by the GABA+ signal amplitude, yielding a relative CRSD, which is inversely related to the signal-to-noise ratio (van der Meer et al., 2007) . Only spectra with a relative CRSD of GABA+ below 10% were included in the final analysis.
Each pixel in the 3D T1-weighted brain images was segmented as gray matter (GM), white matter (WM), or cerebrospinal fluid (CSF) using an automatic brain segmentation program, FAST (FMRIB's automated segmentation tool) in the FSL package (Oxford University, Oxford, UK) (Zhang et al., 2001 ). VOIs were co-registered to the anatomical images using the 'Re-creation of VOI' Matlab tool (Montelius et al., 2008) (Fig. 1c) . Tissue GM fractions were obtained by calculating the ratio of GM volume to the GM + WM volumes in the VOIs. The concentrations of GABA, Cr and NAA in CSF were considered to be negligible.
Statistical analysis
The values are presented as mean ± standard deviation (S.D.). To determine regional effects on GABA+ levels, analysis of covariance was used with age as a covariate. No correction of p values for multiple comparisons was made to account for making measurements in two regions. Linear regression was used to examine the association between age and the GABA+/Cr or GABA+/NAA ratios. In each region, analysis of variance was performed in order to assess the interaction effect between age and gender on GABA+/Cr or GABA+/NAA ratios. Effects of gender on GABA+ levels in each region were tested using two-tailed t-tests. Secondary analyses were also performed for the Glx/Cr signal. Analysis of variance was used to compare the relative CRSD of GABA+ among all the age groups, and linear regression was used to examine the association between age and the relative CRSD of GABA+ in each region. All statistical tests were two-sided and P-values of less than 0.05 were accepted as significant. Statistical analyses were carried out using the statistical package SPSS 13.0.
Results
Edited spectra from the frontal and parietal regions were successfully collected in all 100 participants and the CRSD of GABA+ in all spectra was below 10%, indicating that the MEGA-PRESS technique is robust, even though it relies on subtraction of two scans to detect GABA+. The mean (plus/minus standard deviation) GABA-edited spectra for each decade in each region are shown in Fig. 2 , indicating comparable spectral quality across the full age range.
Effect of age on GABA +
There were significant negative correlations between age and GABA+/Cr or GABA+/NAA in both regions studied (GABA+/Cr: frontal region, r = −0.68, p b 0.001, parietal region, r = −0.54, p b 0.001; GABA+/NAA: frontal region, r = −0.58, p b 0.001, parietal region, r = −0.49, p b 0.001) when data from both men and women are combined, as seen in Figs. 3a and b. Linear regression analysis indicates that there is approximately 5% reduction in GABA+/Cr and 4% reduction in GABA+/NAA occurrences per decade of life. There were also significant negative correlations between age and Glx/Cr in both regions studied (Glx/Cr: frontal region, r = −0.47, p b 0.001, parietal region, r = −0.37, p b 0.001) when data from both men and women are combined.
Effect of gender on age-related changes in GABA+
Separating the results by gender, significant age-related decreases in GABA + were observed in men and women in both regions as described in Table 1 . Interestingly, an analysis of variance showed a significant gender difference in the age-related reduction in GABA + in the frontal region (GABA +/Cr: age × sex, p = 0.03; GABA +/NAA: age × sex, p = 0.001). As shown in Fig. 3c , there was a greater age-related decline in women than in men. There was no significant gender difference in the age-related reduction in Glx in both regions (frontal region: age × sex, p = 0.25; parietal region: age × sex, p = 0.29).
Regional and gender variations of GABA +
The regional GABA+ and Glx/Cr measurements among all subjects are summarized in Table 2 . GABA+ is significantly higher in the frontal region than in the parietal region (GABA+/Cr: p = 0.04; GABA+/NAA: p = 0.03). There was no significant difference between the frontal region and the parietal region for the Glx/Cr ratios, although a trendlevel difference was observed (p = 0.05). There was no significant difference between men and women for the GABA+ ratios in either the frontal region (GABA+/Cr: p = 0.80; GABA+/NAA: p = 0.56) or the parietal region (GABA+/Cr: p = 0.48; GABA+/NAA: p = 0.65), or for Glx/Cr ratios in either the frontal region (p = 0.55) or the parietal region (p = 0.73). 
The ratio of gray matter and white matter in each ROI
The mean gray matter tissue fraction GM/(GM + WM) was 57.85% and 57.95% in the frontal region and parietal region, and did not change significantly with age, although a trend-level association was seen (p = 0.14, p = 0.11) (Figs. 4a and b) , and did not correlate with GABA +/Cr ratios (p = 0.30, p = 0.32) (Figs. 4c and d) or GABA+/NAA ratios (p = 0.39, p = 0.45) or Glx/Cr ratios (p = 0.26, p = 0.73). There were no significant gender-related and region-related differences in the fraction of GM in the VOIs (p = 0.37 and p = 0.82, respectively).
Relative CRSD of GABA+ in each region
The mean relative CRSD of GABA + was 5.33% and 5.12% in the frontal region and parietal region. The relative CRSD of GABA+ for each decade of all subjects in each region are summarized in Table 3 . There were no significant differences among all the age groups for the relative CRSD of GABA+ in the frontal region (p = 0.82) and parietal region (p = 0.76); there were no correlations between age and the relative CRSD of GABA+ in the frontal region (p = 0.98) and the parietal region (p = 0.15).
Discussion
The most important finding of this study was a decrease of GABA+ levels with increasing age in both the frontal region and parietal regions in normal subjects ranging from 20 to 76 years of age.
GABA is primarily localized to inhibitory interneurons, therefore, the observed reduction in GABA concentration with age could be indicative of GABAergic neuronal loss during normal aging. This is consistent with a number of animal studies that have shown a decline in GABAergic neurons with age (Hua et al., 2008; Stanley et al., 2012) . However, there was no correlation of gray matter tissue fraction with age, which may either indicate that there is indeed no decline in overall neuron number, but that the ratio of GABAergic neurons to total neurons decreased with age (Hua et al., 2008) , or that such an effect is not detectable at the macroscopic level. Another study (Marenco et al., 2010) has shown a relationship between MRS GABA levels and genes coding for glutamic acid decarboxylase (GAD), a transaminase involved in the production of GABA. It is therefore also possible that the current finding of reduced GABA+ levels with increasing age may reflect a decline in the efficacy of production in GABA (Caspary et al., 1995; Leventhal et al., 2003; Raza et al., 1994) .
A number of behavioral studies have suggested that a decline in GABAergic inhibition underlies many of the cognitive declines seen with age (Caspary et al., 1995; Yang et al., 2009; Zhang et al., 2008) . Moreover, another study showed that GABA and GABAergic agonists improved visual performance in senescent monkeys (Leventhal et al., 2003) . However, few MRS studies have investigated age-related changes in GABA concentrations, and those that have analyzed non-edited short-TE spectra at field strengths of 1.5 or 3.0 T (Grachev and Apkarian, 2000) , which have limited ability to resolve GABA from glutamate (Glu) and glutamine. Several prior MRS studies have found no relationship between GABA levels and age (e.g. in the frontal region (Goto et al., 2010) and the occipital cortex (Goddard et al., 2001) ); however, these studies were not primarily focused on detecting age-related changes, and had a limited age range which diminished their power to detect such an effect.
In our study, two internal references (Cr and NAA) were used to express relative GABA+ levels. The literature on age-related Cr changes is mixed-some studies have shown no significant change with age (Brooks et al., 2001; Christiansen et al., 1993) and others have shown a slow increase with age (Maudsley et al., 2009; Reyngoudt et al., 2012;  GABA = gamma-aminobutyric acid, Cr = total creatine, NAA = N-acetylaspartate, GABA+ = GABA plus co-edited macromolecules, Glx = glutamate + glutamine. Table 2 GABA+/Cr, GABA+/NAA and Glx/Cr ratios in the frontal region and the parietal region among all subjects. The values are mean ± standard deviation, GABA = gamma-aminobutyric acid, GABA + = GABA plus co-edited macromolecules, CRSD = Cramer-Rao standard deviation. a Comparison of the relative CRSD of GABA+ among all the age groups in each region. Robertson et al., 2001; Saunders et al., 1999) . Thus, it is possible that the observed age-related decrease in GABA/Cr ratio could be driven by an age-related increase in creatine. However, this is unlikely as our results also indicate there was a decrease of GABA+/NAA ratio with age, and many studies have shown that the NAA signal either has no significant change with age (Saunders et al., 1999) , or decreases with age (Brooks et al., 2001; Christiansen et al., 1993) , but does not increase. Therefore the most consistent interpretation of this data is that GABA+ levels are decreasing with age. Secondary analyses also revealed significant (but weaker) age-related reductions in Glx. The co-edited Glx signal arises in the edited difference spectra from the alpha proton of both glutamate and glutamine. Due the mixed nature of the signal, and the extensive metabolic role of glutamate, it is not clear how to interpret these results.
Region of interest
Despite a gender-specific decline of GABA + levels with age, no significant effect of gender itself on GABA+ levels in the frontal region and parietal region was found. One study found that female rats had higher GABA levels than male rats in the frontal cortex (Davis et al., 1999) . A number of MRS studies have investigated the role of gender in GABA levels in humans: reduced levels of GABA in the occipital region in the luteal menstrual phase were found in one study (Epperson et al., 2002) , and in the postpartum period in another (Epperson et al., 2006) . It has been previously shown that the menstrual cycle affects GABA-A receptor expression (Lovick, 2006) . GABA levels were also reported to be significantly higher in men than women in the dorsolateral prefrontal cortex (O'Gorman et al., 2011) . Collectively, these studies suggest that GABA levels may be affected both by gender and hormonal effects. One limitation of the current study was that the menstrual or contraceptive status of female subjects in this study was not recorded.
Several MRS studies have shown regional variations in GABA concentration Goto et al., 2010; Northoff et al., 2007; Zhu and Barker, 2011 ). In the current study, GABA+ levels were significantly higher in the frontal region than those in the parietal region, but the underlying cellular or biochemical cause of this difference is unclear.
It is also difficult to compare GABA +/Cr ratios between this and previous studies, as different acquisition techniques and parameters, as well as analysis methods, are often used. However, one study (Waddell et al., 2011 ) shared a number of methodological similarities to the current study, and measured ratios of GABA +/Cr in anterior cingulate cortex (ACC) and the cerebellar vermis. For the ACC and cerebellum, the reported GABA +/Cr ratios of 0.313 ± 0.08 and 0.229 ± 0.06 respectively, are in a similar range to the values reported here in the frontal and parietal regions (Table 2) .
In this study, no significant difference among all the age groups for the relative CRSD of GABA + in each region was found and there were no correlations between age and the relative CRSD of GABA+ in the frontal region and the parietal region. Thus, it is likely that our spectral quality is relatively consistent for each decade in each region, as suggested by Fig. 2 .
It has been reported that the frontal region is preferentially affected by aging (Brooks et al., 2001 ) and the parietal region is a commonly used control region. Moreover, as the technical limitations of this method required the use of relatively large VOIs (3 × 3 × 3 cm 3 ), it is difficult to totally place the VOI in the occipital or temporal region, especially for the older subjects. Thus, the VOI was chosen in the frontal and parietal regions in our study. In terms of the particular location of the VOIs, the genu and splenium of the corpus callosum are excellent anatomical landmarks to assist with voxel placement; the VOIs were prescribed on the medial aspect of the frontal and parietal regions in order to obtain a higher percentage GM fraction and avoid the skull.
The data acquisition strategy for this study has several limitations. First, the relatively low amplitude of the GABA signal of this method required the use of relatively large VOIs (3 × 3 × 3 cm 3
). An approach enabling the use of smaller VOIs may prove more efficient for region-specific analyses of brain GABA changes. Secondly, the edited GABA signal that was detected contains a significant contribution from co-edited macromolecules, and homocarnosine. Although the decrease in GABA+ could potentially be explained by a decrease in the MM contribution to the GABA+ signal, this is unlikely to be the driving factor as two recent studies have shown that the 3 ppm MM signal increases with age (Hofmann et al., 2001; Mader et al., 2002) . Further studies that remove the MM contribution are required in order to investigate the role of the co-edited MM signal in the observed gender differences. In vivo concentration of homocarnosine is much lower than GABA concentration (Govindaraju et al., 2000) , so it is unlikely that isolated changes in homocarnosine are the main factor driving the observed changes. Thirdly, the study acquisition protocol did not include acquisitions of non-suppressed water scans, meaning that we were only able to present metabolite ratios rather than concentrations relative to water as an internal standard.
In conclusion, brain both GABA+/Cr and GABA+/NAA ratios decrease with age in the frontal region and parietal region, with a more rapid frontal decline in women. Both GABA+/Cr and GABA+/NAA ratios are significantly higher in the frontal region than the parietal region. Given the increasing use of MRS of GABA to study both normal brain function and pathologies, normative studies of age-related and regional differences in GABA are an important undertaking.
